Last reviewed · How we verify

NCT02880553: QUALVIE-SEP

Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis

Completed Last updated 28 July 2017
What this trial tests

trial in Multiple Sclerosis in 150 participants. Completed in 9 March 2017.

Timeline
23 August 2016
Primary endpoint
9 March 2017
9 March 2017

Quick facts

Lead sponsorFondation Ophtalmologique Adolphe de Rothschild
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date23 August 2016
Primary completion9 March 2017
Estimated completion9 March 2017
Sites1 location across Italy

Conditions studied

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild — full company profile →

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The World Health Organization International Classification of Functioning, Disability and Health has shown that the environment can play a major role in patients' disability, and hence in their quality of life. This study considers social dimensions of quality of life, particularly family as well as social and professional networks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Fondation Ophtalmologique Adolphe de Rothschild trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02880553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing